Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Mov Disord. 2010 Nov 15;25(15):2682–2685. doi: 10.1002/mds.23287

Figure 1. Scatter plots of CSF Aβ42 and P181-tau concentrations.

Figure 1

Individuals’ CSF Aβ42 and P181-tau concentrations for (A) both Control groups, subjects with amnestic Mild Cognitive Impairment (MCI), and patients with Alzheimer’s Disease (AD), and for (B) patients with Parkinson’s disease (PD) without cognitive impairment (CI), with CI but Not Dementia (PD-CIND), or dementia (PD-D).